Screening the MayBridge Rule of 3 Fragment Library for Compounds That Interact with the Trypanosoma Brucei Myo-Inositol-3-Phosphate Synthase And/or Show Trypanocidal Activity

Overview

Journal Mol Biol Int

Publisher Hindawi

Specialty Molecular Biology

Date 2011 Nov 18

PMID 22091402

Citations 5

Authors

Louise L Major

Terry K Smith

Affiliations

Soon will be listed here.

Abstract

Inositol-3-phosphate synthase (INO1) has previously been genetically validated as a drug target against Trypanosoma brucei, the causative agent of African sleeping sickness. Chemical intervention of this essential enzyme could lead to new therapeutic agents. Unfortunately, no potent inhibitors of INO1 from any organism have been reported, so a screen for potential novel inhibitors of T. brucei INO1was undertaken. Detection of inhibition of T. brucei INO1 is problematic due to the nature of the reaction. Direct detection requires differentiation between glucose-6-phosphate and inositol-3-phosphate. Coupled enzyme assays could give false positives as potentially they could inhibit the coupling enzyme. Thus, an alternative approach of differential scanning fluorimetry to identify compounds that interact with T. brucei INO1 was employed to screen ~670 compounds from the MayBridge Rule of 3 Fragment Library. This approach identified 38 compounds, which significantly altered the T(m) of TbINO1. Four compounds showed trypanocidal activity with ED50s in the tens of micromolar range, with 2 having a selectivity index in excess of 250. The trypanocidal and general cytotoxicity activities of all of the compounds in the library are also reported, with the best having ED50S of ~20 μM against T. brucei.

Citing Articles

Rational design of FXR agonists: a computational approach for NASH therapy.

Gandhe A, Kumari S, Sobhia M Mol Divers. 2023; 28(5):3363-3376.

PMID: 38055145 DOI: 10.1007/s11030-023-10766-9.

Toward Chemical Validation of Leishmania infantum Ribose 5-Phosphate Isomerase as a Drug Target.

Dickie E, Ronin C, Sa M, Ciesielski F, Trouche N, Tavares J Antimicrob Agents Chemother. 2021; 65(7):e0189220.

PMID: 33875438 PMC: 8373210. DOI: 10.1128/AAC.01892-20.

Identification of an inositol-3-phosphate synthase 1-B gene (AccIPS1-B) from Apis cerana cerana and its role in abiotic stress.

Ni Y, Li G, Ji X, Yang Y, Guo X, Sun Q Cell Stress Chaperones. 2019; 24(6):1101-1113.

PMID: 31512154 PMC: 6882988. DOI: 10.1007/s12192-019-01032-9.

An RNAi-based high-throughput screening assay to identify small molecule inhibitors of hepatitis B virus replication.

Ghosh S, Kaushik A, Khurana S, Varshney A, Singh A, Dahiya P J Biol Chem. 2017; 292(30):12577-12588.

PMID: 28584057 PMC: 5535032. DOI: 10.1074/jbc.M117.775155.

Pharmacological chaperone for α-crystallin partially restores transparency in cataract models.

Makley L, McMenimen K, DeVree B, Goldman J, McGlasson B, Rajagopal P Science. 2015; 350(6261):674-7.

PMID: 26542570 PMC: 4725592. DOI: 10.1126/science.aac9145.

References

Nagamune K, Nozaki T, Maeda Y, Ohishi K, Fukuma T, Hara T . Critical roles of glycosylphosphatidylinositol for Trypanosoma brucei. Proc Natl Acad Sci U S A. 2000; 97(19):10336-41. PMC: 27025. DOI: 10.1073/pnas.180230697. View

Movahedzadeh F, Smith D, Norman R, Dinadayala P, Murray-Rust J, Russell D . The Mycobacterium tuberculosis ino1 gene is essential for growth and virulence. Mol Microbiol. 2004; 51(4):1003-14. DOI: 10.1046/j.1365-2958.2003.03900.x. View

Chaplen F . Incidence and potential implications of the toxic metabolite methylglyoxal in cell culture: A review. Cytotechnology. 2012; 26(3):173-83. PMC: 3449548. DOI: 10.1023/A:1007953628840. View

Martin K, Smith T . The glycosylphosphatidylinositol (GPI) biosynthetic pathway of bloodstream-form Trypanosoma brucei is dependent on the de novo synthesis of inositol. Mol Microbiol. 2006; 61(1):89-105. PMC: 3793301. DOI: 10.1111/j.1365-2958.2006.05216.x. View

Smith T, Crossman A, Brimacombe J, Ferguson M . Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness. EMBO J. 2004; 23(23):4701-8. PMC: 533043. DOI: 10.1038/sj.emboj.7600456. View

Martin K, Smith T . Phosphatidylinositol synthesis is essential in bloodstream form Trypanosoma brucei. Biochem J. 2006; 396(2):287-95. PMC: 1462709. DOI: 10.1042/BJ20051825. View

Ilg T . Generation of myo-inositol-auxotrophic Leishmania mexicana mutants by targeted replacement of the myo-inositol-1-phosphate synthase gene. Mol Biochem Parasitol. 2002; 120(1):151-6. DOI: 10.1016/s0166-6851(01)00435-2. View

Ferguson M, Duszenko M, Lamont G, Overath P, Cross G . Biosynthesis of Trypanosoma brucei variant surface glycoproteins. N-glycosylation and addition of a phosphatidylinositol membrane anchor. J Biol Chem. 1986; 261(1):356-62. View

Ferguson M, Low M, Cross G . Glycosyl-sn-1,2-dimyristylphosphatidylinositol is covalently linked to Trypanosoma brucei variant surface glycoprotein. J Biol Chem. 1985; 260(27):14547-55. View

10.

Lo M, Aulabaugh A, Jin G, Cowling R, Bard J, Malamas M . Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal Biochem. 2004; 332(1):153-9. DOI: 10.1016/j.ab.2004.04.031. View

11.

Mikus J, Steverding D . A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue. Parasitol Int. 2001; 48(3):265-9. DOI: 10.1016/s1383-5769(99)00020-3. View

12.

Aitcheson N, Talbot S, Shapiro J, Hughes K, Adkin C, Butt T . VSG switching in Trypanosoma brucei: antigenic variation analysed using RNAi in the absence of immune selection. Mol Microbiol. 2005; 57(6):1608-22. PMC: 1618954. DOI: 10.1111/j.1365-2958.2005.04795.x. View

13.

Henry S, Atkinson K, Kolat A, Culbertson M . Growth and metabolism of inositol-starved Saccharomyces cerevisiae. J Bacteriol. 1977; 130(1):472-84. PMC: 235226. DOI: 10.1128/jb.130.1.472-484.1977. View

14.

Barber M . The antibacterial activity of simple derivatives of 2-aminophenol. Biochem J. 1945; 39(4):285-7. PMC: 1258228. View

15.

Ferguson M, Cross G . Myristylation of the membrane form of a Trypanosoma brucei variant surface glycoprotein. J Biol Chem. 1984; 259(5):3011-5. View

16.

Niesen F, Berglund H, Vedadi M . The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat Protoc. 2007; 2(9):2212-21. DOI: 10.1038/nprot.2007.321. View

17.

Martin K, Smith T . The myo-inositol-1-phosphate synthase gene is essential in Trypanosoma brucei. Biochem Soc Trans. 2005; 33(Pt 5):983-5. DOI: 10.1042/BST0330983. View

18.

Jin X, Foley K, Geiger J . The structure of the 1L-myo-inositol-1-phosphate synthase-NAD+-2-deoxy-D-glucitol 6-(E)-vinylhomophosphonate complex demands a revision of the enzyme mechanism. J Biol Chem. 2003; 279(14):13889-95. DOI: 10.1074/jbc.M308986200. View

19.

WEISBURGER E, Murthy A, FLEISCHMAN R, HAGOPIAN M . Carcinogenicity of 4-chloro-o-phenylenediamine, 4-chloro-m-phenylenediamine, and 2-chloro-p-phenylenediamine in Fischer 344 rats and B6C3F1 mice. Carcinogenesis. 1980; 1(6):495-9. DOI: 10.1093/carcin/1.6.495. View

20.

Ferguson M, BRIMACOMBE J, Brown J, Crossman A, Dix A, Field R . The GPI biosynthetic pathway as a therapeutic target for African sleeping sickness. Biochim Biophys Acta. 1999; 1455(2-3):327-40. DOI: 10.1016/s0925-4439(99)00058-7. View